143 related articles for article (PubMed ID: 37087578)
1. [Peripheral blood
Zang Z; Qiao R; Zhu Q; Zhou X; Gu W; Han B; Yang R
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):349-359. PubMed ID: 37087578
[TBL] [Abstract][Full Text] [Related]
2. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
3. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.
Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S
Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
5. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
[TBL] [Abstract][Full Text] [Related]
6. Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma.
Qiao R; Zhong R; Liu C; Di F; Zhang Z; Wang L; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Genes Genomics; 2022 Apr; 44(4):445-453. PubMed ID: 34783986
[TBL] [Abstract][Full Text] [Related]
7.
Li M; Qiao R; Zhong R; Wei Y; Wang J; Zhang Z; Wang L; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Biomarkers; 2022 Feb; 27(1):79-85. PubMed ID: 34882057
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.
Mansfield AS; Wang L; Cunningham JM; Jen J; Kolbert CP; Sun Z; Yang P
Cancer Genet; 2015 May; 208(5):253-60. PubMed ID: 25650174
[TBL] [Abstract][Full Text] [Related]
9. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Shi S; Xu M; Xi Y
Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
[TBL] [Abstract][Full Text] [Related]
11. [Peripheral blood
Zhou X; Lei S; Li L; Xu T; Gu W; Ma F; Yang R
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1456-1463. PubMed ID: 34755660
[TBL] [Abstract][Full Text] [Related]
12. The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case-Control Cohort.
Qiao R; Di F; Wang J; Wei Y; Zhang Y; Xu T; Wang Y; Gu W; Han B; Yang R
Cancer Manag Res; 2020; 12():11063-11075. PubMed ID: 33173339
[TBL] [Abstract][Full Text] [Related]
13. Novel blood-based FUT7 DNA methylation is associated with lung cancer: especially for lung squamous cell carcinoma.
Fang Y; Qu Y; Ji L; Sun H; Li J; Zhao Y; Liang F; Wang Z; Su J; Liu J; Dai L; Ouyang S
Clin Epigenetics; 2022 Dec; 14(1):167. PubMed ID: 36463240
[TBL] [Abstract][Full Text] [Related]
14. WT1 CpG islands methylation in human lung cancer: a pilot study.
Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.
Christensen BC; Marsit CJ; Houseman EA; Godleski JJ; Longacker JL; Zheng S; Yeh RF; Wrensch MR; Wiemels JL; Karagas MR; Bueno R; Sugarbaker DJ; Nelson HH; Wiencke JK; Kelsey KT
Cancer Res; 2009 Aug; 69(15):6315-21. PubMed ID: 19638575
[TBL] [Abstract][Full Text] [Related]
16. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas.
Shiraishi M; Sekiguchi A; Oates AJ; Terry MJ; Miyamoto Y
Oncogene; 2002 May; 21(22):3659-62. PubMed ID: 12032868
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.
Loh M; Liem N; Vaithilingam A; Lim PL; Sapari NS; Elahi E; Mok ZY; Cheng CL; Yan B; Pang B; Salto-Tellez M; Yong WP; Iacopetta B; Soong R
BMC Gastroenterol; 2014 Mar; 14():55. PubMed ID: 24674026
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.
Zhu Q; Qiao R; Di F; Song Y; Zhang J; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Clin Chim Acta; 2022 Dec; 537():173-180. PubMed ID: 36332669
[TBL] [Abstract][Full Text] [Related]
19. XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma.
Zeng H; Wang Y; Wang Y; Zhang Y
Medicine (Baltimore); 2021 Jan; 100(1):e24150. PubMed ID: 33429795
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]